Bicycle Day 2026: 83 Years of Psychedelic Medicine — and a Historic Turning Point

SAGE SOUL  |  APRIL 19, 2026

Bicycle Day 2026: 83 Years of Psychedelic Medicine — and a Historic Turning Point

On the anniversary of the world's first acid trip, the United States takes its most significant step toward psychedelic medicine in over six decades.

Every April 19th, a small but growing community of researchers, healers, therapists, and curious minds marks a peculiar anniversary: the day a Swiss chemist named Albert Hofmann climbed on a bicycle while under the influence of a compound he had synthesized — and inadvertently changed the history of mental health forever. That day was April 19, 1943. Today, we call it Bicycle Day.

This year, the commemoration arrives with extraordinary context. Just one day before Bicycle Day 2026, President Trump signed an executive order directing the federal government to fast-track review of psychedelic medicines, commit $50 million to state-level programs, and open new pathways for patients to access these treatments. It is the most significant federal policy shift on psychedelics in over sixty years — and it happened on the eve of the holiday that honors the very compound that started it all.

The Bicycle Ride That Launched a Revolution

Albert Hofmann was not looking for a mind-altering substance. Working as a chemist at Sandoz Laboratories in Basel, Switzerland, he had spent years systematically studying compounds derived from ergot — a rye fungus — in search of treatments for respiratory and circulatory conditions. In 1938, he synthesized lysergic acid diethylamide, or LSD, as the 25th compound in a series of ergot derivatives. Initial tests on animals showed nothing remarkable, and the compound was shelved. [1]

Five years later, in April 1943, something drew Hofmann back to his creation. While resynthesizing a fresh batch, he inadvertently absorbed a small amount through his skin. He left work early feeling strangely altered — what he described in his notes as "a not unpleasant intoxicated-like condition, characterized by an extremely stimulated imagination." [2]

Three days later, on April 19th, he deliberately ingested 250 micrograms — a dose he assumed was modest but which turned out to be several times the threshold for psychedelic effects. By 5:00 p.m., the effects were unmistakable. At a loss to write further, he asked his laboratory assistant to escort him home. Because wartime restrictions had banned private car use on the roads, they traveled by bicycle. [3]

"I was taken to another world, another place, another time." — Albert Hofmann

Hofmann's account of the ride home describes wavering vision, the sensation of being unable to move despite traveling quickly, and moments of both terror and awe. His assistant reported they arrived safely. That evening, a doctor found his physical vitals normal. The experience resolved into what Hofmann described as a state of clarity and profound well-being. [3]

Bicycle Day — the name coined in 1985 by Thomas Roberts, a professor at Northern Illinois University — marks that April 19th ride as the beginning of the psychedelic era. [4] Hofmann himself called LSD "medicine for the soul" and lived to 102, spending his final decades frustrated by its prohibition. "It was used very successfully for ten years in psychoanalysis," he said near the end of his life. [5]

The Science That Was Suppressed — and Revived

The 1950s and early 1960s saw an explosion of legitimate psychiatric research into psychedelics. Researchers reported promising results using LSD and related compounds to treat addiction, depression, and anxiety. The U.S. government, including the military, was deeply involved in early psychedelic research during this period — though not always for therapeutic purposes. [6]

That research effectively ended when LSD became entangled with the counterculture of the 1960s. Recreational use grew, public alarm followed, and by the early 1970s, LSD and related compounds had been classified as Schedule I controlled substances — the most restrictive federal category, reserved for drugs with "no accepted medical use." Government-funded research came to a halt. [7]

The revival began slowly. Academic researchers at institutions including Johns Hopkins, NYU, and Imperial College London began publishing peer-reviewed studies in the early 2000s, initially on psilocybin (the active compound in "magic mushrooms") and later on MDMA, ibogaine, and LSD. Their findings were striking enough that the FDA granted Breakthrough Therapy designations to psilocybin for treatment-resistant depression and MDMA for PTSD — a designation reserved for drugs showing substantial improvement over existing treatments. [8]

A landmark 2025 study published in the Journal of the American Medical Association found that a single dose of LSD could meaningfully reduce anxiety and depression for months in clinical participants. [6] The research base has grown large enough that it can no longer be ignored — and now, it has reached the highest levels of federal policy.

The Executive Order: What Changed on April 18, 2026

On Saturday, April 18th, 2026, President Trump signed an executive order at the Oval Office that marks the most consequential federal shift in psychedelic policy since Schedule I classification. The order was signed with Health Secretary Robert F. Kennedy Jr., NIH Director Jay Bhattacharya, and Joe Rogan present — the latter credited by Trump as having raised the issue with him directly. [9]

"Today's order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives," Trump said as he signed. [7]

The executive order does several things:

• Directs the FDA to expedite review of psychedelic drugs that have already received Breakthrough Therapy designations, specifically including psilocybin, ibogaine, MDMA, and LSD. [8]

• Grants Commissioner's National Priority Vouchers to qualifying psychedelic drugs, removing red tape from the FDA's gold-standard review process. [10]

• Opens a right-to-try pathway for eligible patients — including terminally ill individuals — to access investigational psychedelic drugs including ibogaine outside of standard regulatory pathways. [8]

• Commits $50 million to states that have enacted or are developing psychedelic treatment programs, establishing a federal-state partnership for funding, technical assistance, and data sharing. [7]

• Directs HHS, the FDA, the VA, and private sector partners to expand clinical trial participation and evidence generation for experimental psychedelic therapies. [10]

  
  

The focus on veterans is central. The Department of Veterans Affairs is currently participating in at least five psychedelic trials across New York, California, and Oregon. The state of Texas launched a dedicated research consortium in 2025 to accelerate ibogaine development specifically for PTSD and addiction among veterans. [10]

FDA Commissioner Marty Makary confirmed that three priority review vouchers for serotonin 2a agonist psychedelics — a class that includes LSD and psilocybin — would be issued within days of the signing. [8]

What This Means for the Healing Community

The cultural arc here is remarkable. Hofmann spent the final decades of his life arguing that LSD had been wrongly condemned — that with proper set, setting, and clinical supervision, it offered genuine psychiatric benefit. He was largely ignored by policymakers. Now, 83 years after that bicycle ride, the federal government is moving — imperfectly, incrementally, but unmistakably — toward the vision he held.

For those of us who work in the healing space, this moment carries both opportunity and responsibility. Psychedelics are not a substitute for integration work, relational support, somatic grounding, or the inner work required to metabolize what these medicines reveal. Research consistently shows that the therapeutic container — the preparation, the setting, the integration afterward — is inseparable from the outcome. [11]

These medicines amplify what is already present. That is why the relational, somatic, and spiritual frameworks we work with are not supplementary to this moment — they are essential to it.

The opening of psychedelic medicine to mainstream clinical access will bring many people to these experiences for the first time, often without the wisdom traditions, ceremonial containers, or integration practices that communities have developed over generations. The work of healers, coaches, integration specialists, and somatic practitioners will be more necessary — not less — as these medicines become more accessible.

At Sage Soul, this is exactly the terrain we work in. Whether through sound healing, IFS (Internal Family Systems), somatic work, or integration coaching, our practice is built on the understanding that healing requires a container — and that the container is everything.

A Note on Albert Hofmann

Hofmann always hoped his discovery would be redeemed. He called LSD his "problem child" — brilliant but misunderstood, full of potential that had been obscured by fear and politics. He interviewed with researchers and journalists well into his nineties, still making the case for responsible psychedelic research. He died in 2008 at the age of 102.

On this Bicycle Day, the trajectory of history has shifted in a direction he would have recognized. The compound he synthesized in 1938, shelved, rediscovered in 1943, and then watched be made illegal — is now the subject of federal executive action, clinical trials at major universities, and a growing body of evidence that it can, in the right conditions, help people heal.

That is worth honoring today. And it is worth doing the work to make sure the healing that follows is done wisely.

About the Author

Shelley DeMarco is the founder of Sage Soul, a holistic wellness and healing practice offering sound healing, IFS-based integration coaching, retreats, and transformation programs. She works at the intersection of consciousness, healing, and somatic practice. Learn more at sagesoul.com.

Citations & Sources

[1] Rolling Stone. "This Bicycle Day, Celebrate Albert Hofmann's Psychedelic Discovery.." Rolling Stone, 2023. https://www.rollingstone.com/culture/culture-news/bicycle-day-albert-hofmann-lsd-psychedelic-986279/

[2] Britannica. "Today in History April 19: Albert Hofmann, LSD, Acid, Bike Ride, & First Trip.." Britannica, 2026. https://www.britannica.com/today-in-history/April-19-The-Very-First-Acid-Trip-in-History

[3] iMinds / University of Victoria. "Bicycle Day's Dilemma: From the Writings of Albert Hofmann.." Centre for Addictions Research of BC, n.d.. https://www.uvic.ca/research/centres/cisur/assets/docs/iminds/bicycle-hdt.pdf

[4] Wikipedia. "Bicycle Day (Psychedelic Holiday).." Wikipedia, 2026. https://en.wikipedia.org/wiki/Bicycle_Day_(psychedelic_holiday)

[5] Wikipedia. "Albert Hofmann.." Wikipedia, 2026. https://en.wikipedia.org/wiki/Albert_Hofmann

[6] NPR. "Trump Signs Order Fast-Tracking Review of Psychedelics for Mental Health Disorders.." NPR, April 18, 2026. https://www.npr.org/2026/04/18/nx-s1-5789859/psychedelic-treatments-mental-health

[7] PBS NewsHour. "Trump Signs Order to Hasten Review of Psychedelics.." PBS, April 18, 2026. https://www.pbs.org/newshour/politics/trump-signs-order-to-speed-review-of-psychedelics

[8] STAT News. "How Trump Is Pushing Psychedelics Reform Through the Health Agencies.." STAT News, April 18, 2026. https://www.statnews.com/2026/04/18/psychedelics-ptsd-mental-health-research-boost-from-trump-executive-order/

[9] MS Now. "Trump Signs Executive Order on Psychedelic Drugs — with Joe Rogan by His Side.." MS Now, April 19, 2026. https://www.ms.now/news/trump-executive-order-psychedelic-drugs-joe-rogan

[10] The White House. "Fact Sheet: President Donald J. Trump Is Accelerating Medical Treatments for Serious Mental Illness.." WhiteHouse.gov, April 18, 2026. https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-is-accelerating-medical-treatments-for-serious-mental-illness/

[11] NPR. "Bicycle Day Marks an Unofficial Commemoration of the First Use of LSD.." NPR, April 19, 2024. https://www.npr.org/2024/04/19/1245810413/bicycle-day-marks-an-unofficial-commemoration-of-the-first-use-of-lsd